
Melanoma Research Alliance
The Melanoma Research Alliance exists to accelerate treatment options and find a cure for melanoma.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | $20.0m | Early VC | |
Total Funding | 000k |
Related Content
The Melanoma Research Alliance (MRA) is a public charity committed to advancing the fight against melanoma.
As the largest non-profit funder of melanoma research globally, MRA's primary activity is providing grants for scientific investigation. The organization has invested over $150 million, supporting more than 440 grant awards. Its funding strategy is comprehensive, covering a wide spectrum of research areas, including prevention, diagnosis, and treatment of melanoma.
MRA operates on a collaborative model, forming partnerships with individuals, private foundations, and corporations to amplify its impact. These collaborations are crucial for funding a diverse portfolio of research projects, from individual investigator-led studies to large-scale, multi-institutional team science projects.
In addition to research funding, the organization provides a range of support resources for patients and their families. This includes the Melanoma > Exchange, an online community platform where individuals affected by melanoma can connect, share experiences, and find support. MRA also offers educational materials and resources to help patients navigate their diagnosis and treatment options.
Keywords: melanoma research, nonprofit funder, grant awards, scientific investigation, cancer research, patient support, collaborative partnerships, medical research, oncology, dermatology